These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 30984626)
1. Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus. Acevedo OA; Díaz FE; Beals TE; Benavente FM; Soto JA; Escobar-Vera J; González PA; Kalergis AM Front Cell Infect Microbiol; 2019; 9():75. PubMed ID: 30984626 [TBL] [Abstract][Full Text] [Related]
2. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells. Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966 [TBL] [Abstract][Full Text] [Related]
3. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity. Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397 [TBL] [Abstract][Full Text] [Related]
4. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression. Farrag MA; Almajhdi FN Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242 [TBL] [Abstract][Full Text] [Related]
5. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice. Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474 [TBL] [Abstract][Full Text] [Related]
6. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection. Bohmwald K; Gálvez NMS; Canedo-Marroquín G; Pizarro-Ortega MS; Andrade-Parra C; Gómez-Santander F; Kalergis AM Front Immunol; 2019; 10():452. PubMed ID: 30936869 [TBL] [Abstract][Full Text] [Related]
7. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Rey-Jurado E; Kalergis AM Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273842 [TBL] [Abstract][Full Text] [Related]
8. Antibody development for preventing the human respiratory syncytial virus pathology. Soto JA; Gálvez NMS; Pacheco GA; Bueno SM; Kalergis AM Mol Med; 2020 Apr; 26(1):35. PubMed ID: 32303184 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection. Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546 [TBL] [Abstract][Full Text] [Related]
11. Human Respiratory Syncytial Virus: Infection and Pathology. Bohmwald K; Espinoza JA; Rey-Jurado E; Gómez RS; González PA; Bueno SM; Riedel CA; Kalergis AM Semin Respir Crit Care Med; 2016 Aug; 37(4):522-37. PubMed ID: 27486734 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory damage on respiratory and nervous systems due to hRSV infection. Bohmwald K; Espinoza JA; Becerra D; Rivera K; Lay MK; Bueno SM; Riedel CA; Kalergis AM Curr Opin Immunol; 2015 Oct; 36():14-21. PubMed ID: 26026788 [TBL] [Abstract][Full Text] [Related]
13. New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. Gálvez NMS; Soto JA; Kalergis AM Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800119 [TBL] [Abstract][Full Text] [Related]
14. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus. Rey-Jurado E; Soto J; Gálvez N; Kalergis AM Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702 [TBL] [Abstract][Full Text] [Related]
16. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection. González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218 [TBL] [Abstract][Full Text] [Related]
17. van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038 [TBL] [Abstract][Full Text] [Related]
18. TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine. Rey-Jurado E; Bohmwald K; Correa HG; Kalergis AM Viruses; 2020 Feb; 12(2):. PubMed ID: 32093256 [TBL] [Abstract][Full Text] [Related]
19. Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644 [TBL] [Abstract][Full Text] [Related]
20. CD8+ T cell immunity against human respiratory syncytial virus. Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]